pilsicainide has been researched along with isoproterenol in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aiba, T; Kamakura, S; Kurita, T; Shimizu, W | 1 |
Katoh, T; Kobayashi, Y; Morita, N; Ohara, T; Takano, T; Takayama, H; Yodogawa, K | 1 |
Morita, H; Morita, ST; Wu, J; Zipes, DP | 1 |
Hirao, K; Obayashi, T; Yagishita, A; Yamauchi, Y | 1 |
4 other study(ies) available for pilsicainide and isoproterenol
Article | Year |
---|---|
Paradoxic abbreviation of repolarization in epicardium of the right ventricular outflow tract during augmentation of Brugada-type ST segment elevation.
Topics: Anti-Arrhythmia Agents; Bundle-Branch Block; Cardiotonic Agents; Electrocardiography; Heart Ventricles; Humans; Isoproterenol; Lidocaine; Male; Middle Aged; Syndrome; Ventricular Fibrillation; Ventricular Function, Right | 2001 |
High-frequency potentials developed in wavelet-transformed electrocardiogram as a novel indicator for detecting Brugada syndrome.
Topics: Action Potentials; Adrenergic beta-Agonists; Adult; Aged; Anti-Arrhythmia Agents; Brugada Syndrome; Cilostazol; Electrocardiography; Heart Conduction System; Humans; Isoproterenol; Lidocaine; Male; Middle Aged; Research Design; Tetrazoles; Time Factors; Vasodilator Agents | 2006 |
Genotype-phenotype correlation in tissue models of Brugada syndrome simulating patients with sodium and calcium channelopathies.
Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Anti-Arrhythmia Agents; Body Surface Potential Mapping; Brugada Syndrome; Calcium Channel Blockers; Channelopathies; Dogs; Endocardium; Genotype; Isoproterenol; Lidocaine; Male; Pericardium; Phenotype; Pinacidil; Sodium Channels; Tissue Culture Techniques; Vasodilator Agents; Verapamil | 2010 |
Idiopathic ventricular fibrillation associated with early repolarization which was unmasked by a sodium channel blocker after catheter ablation of atrial fibrillation.
Topics: Atrial Fibrillation; Catheter Ablation; Electrocardiography; Female; Follow-Up Studies; Humans; Injections, Intravenous; Isoproterenol; Lidocaine; Middle Aged; Risk Assessment; Sodium Channel Blockers; Treatment Outcome; Ventricular Fibrillation | 2014 |